Acadia Pharmaceuticals Inc.
—- Market cap
- $4.77B
- Debt
- —
- Cash
- −$177.70M
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · price snapshotP/E 12.03x
$27.68Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at PRLB's multiple
$211.42663.8% above market
2.30 ACAD Annual EPS×91.92x PRLB P/E=$211.42
Market $27.68Implied $211.42
PRLB · price snapshotP/E 91.92x
$80.89Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at ACAD's multiple
$10.5986.9% below market
0.88 PRLB Annual EPS×12.03x ACAD P/E=$10.59
Market $80.89Implied $10.59